Reports
Reports
Sale
The North America GMO testing market size is forecasted to grow at a CAGR of 6.80% during the forecast period of 2024-2032. This market is driven by the increasing adoption of GMOs in agriculture, growing awareness and need for the transparency, food safety concerns and advancements in testing technologies.
Genetically modified organisms are the plants, animals, microbes whose genetic material have been genetically engineered for their improved activities. Genetic engineering is a laboratory technique which involves isolation, modification of the gene of interest followed by the insertion in the host genome that leads to transformation of the host. These GMOs are then utilized in agriculture, medical field and industries. GMOs are involved to make the soil more fertile, which reduces the growing period of the crops thus increasing the yield of the field. GMOs are involved in plant fortification, that enhances the nutritional qualities of the plants, making them healthier for consumption. All these features contribute to the North America GMO testing market demand.
GMO testing is of two types: DNA based testing and protein-based testing. DNA based testing involves the detection and analysis of the specific DNA sequences in the GMO using PCR. Protein based testing involves detection of the expression of specific proteins by ELISA (use of specific antibodies that bind to the target proteins).
Based on segmentations, the market is divided into technology, trait, crop type, food type and region.
Market Breakup by Technology
Market Breakup by Trait
North America GMO Testing Market Segmentation by Crop Type
Market Breakup by Food Type
Market Breakup by Region
The market for GMO testing is driven by the increasing customer awareness and the need for transparency. Nowadays, people are shifting towards organic farm grown food products which increases the need for GMO Testing for the assurance. GMO testing helps in the determination of the presence of constituents that may be toxic or allergenic to people who are consuming GMO food products. With the growing export of the agricultural products, it requires the products/ crops to be genetically tested according to the international standards. These factors significantly contribute to the rising North America GMO testing market value.
With the advances in technology, the efficacy, accuracy and sensitivity of the GMO testing has also increased. Government regulations to certify each product containing GMO has also been very beneficial for the GMO testing market. Increasing adoption of GMO crops by the farmers as they increase the yield and are resistant to pests and diseases is increasing the growth of the GMO testing market.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players GMO testing companies in North America, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Technology |
|
Breakup by Trait |
|
Breakup by Crop Type |
|
Breakup by Food Type |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America GMO Testing Market Overview
3.1 North America GMO Testing Market Historical Value (2017-2023)
3.2 North America GMO Testing Market Forecast Value (2024-2032)
4 North America GMO Testing Market Landscape
4.1 North America GMO Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America GMO Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Food Type
5 North America GMO Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America GMO Testing Market Segmentation
6.1 North America GMO Testing Market by Technology
6.1.1 Market Overview
6.1.2 Genetic Analysis
6.1.3 Immuno-Analysis
6.2 North America GMO Testing Market by Trait
6.2.1 Market Overview
6.2.2 Stacked
6.2.3 Herbicide Tolerance
6.2.4 Insect Resistance
6.3 North America GMO Testing Market by Crop Type
6.3.1 Market Overview
6.3.2 Corn
6.3.3 Soybean
6.3.4 Canola/Rapeseed
6.3.5 Potato
6.3.6 Others
6.4 North America GMO Testing Market by Food Type
6.4.1 Market Overview
6.4.2 Bakery & Confectionery
6.4.3 Meat & Meat Products
6.4.4 Breakfast Cereals & Snacks
6.4.5 Food Additives
6.4.6 Others
6.5 North America GMO Testing Market by Country
6.5.1 Market Overview
6.5.2 United States of America
6.5.3 Canada
7 Patent Analysis
7.1 Analysis by Type of Patent
7.2 Analysis by Publication year
7.3 Analysis by Issuing Authority
7.4 Analysis by Patent Age
7.5 Analysis by CPC Analysis
7.6 Analysis by Patent Valuation
7.7 Analysis by Key Players
8 Grants Analysis
8.1 Analysis by year
8.2 Analysis by Amount Awarded
8.3 Analysis by Issuing Authority
8.4 Analysis by Grant Application
8.5 Analysis by Funding Institute
8.6 Analysis by NIH Departments
8.7 Analysis by Recipient Organization
9 Funding Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Partnership and Collaborations Analysis
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership
10.3 Analysis by Leading Players
10.4 Analysis by Geography
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Supplier Landscape
12.1 SGS SA
12.1.1 Financial Analysis
12.1.2 Product Portfolio
12.1.3 Demographic Reach and Achievements
12.1.4 Mergers and Acquisition
12.1.5 Certifications
12.2 Eurofins Scientific
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisition
12.2.5 Certifications
12.3 Intertek Group Plc.
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisition
12.3.5 Certifications
12.4 BIO-RAD
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisition
12.4.5 Certifications
12.5 BUREAU VERITAS
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisition
12.5.5 Certifications
12.6 IEH Laboratories & Consulting Group
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisition
12.6.5 Certifications
12.7 MERIEUX NutriSciences
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisition
12.7.5 Certifications
12.8 Microbac Laboratories, Inc.
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisition
12.8.5 Certifications
12.9 OMIC USA
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisition
12.9.5 Certifications
12.10 Thermo Fisher Scientific, Inc.
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisition
12.10.5 Certifications
13 North America GMO Testing Market - Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
16.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market is anticipated to grow at a CAGR of 6.80% during the forecast period of 2024-2032.
The growth of the market is driven by factors like the increasing adoption of GMOs in agriculture, growing awareness and need for the transparency, food safety concerns, advancements in testing technologies and the impact of GMOs in agriculture requires GMO testing.
The key trends which are bolstering the market growth include rising demand for non- GMO and organic products, expansion of testing to non-food structures, technological advances in testing methods and implementation of standardized regulations for GMO testing methods.
The major types of technologies used in the market include genetic analysis and immuno-analysis.
The major crop types in GMO testing market are corn, soybean, canola/rapeseed, potato and others.
The major food types in GMO testing market are bakery and confectionery, meat and meat products, breakfast cereals and snacks, food additives, among others.
The traits can be categorised into stacked, herbicide tolerance, and insect resistance.
The major regional markets include United States of America and Canada.
The key players in the market can be categorised into SGS SA, Intertek Group Plc., BIO-RAD, BUREAU VERITAS, IEH Laboratories & Consulting Group, MERIEUX NutriSciences, Microbac Laboratories Inc., OMIC USA, and Thermo Fisher Scientific, Inc., and Eurofins Scientific.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.